Displaying 25 - 36 of 39
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
General Hepatology
6

Intercept: FXR agonism in clinical practice: new perspectives from the real-world experience in PBC - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Viral Hepatitis
5

Gilead: A NEW VIRUS IN THE MIX: Re-imagining liver disease care in the COVID-19 era - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Displaying 25 - 36 of 39